Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-856-6 | CAS number: 498-15-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on
bioaccumulation potential result:
Turpentine oil, alpha pinene and delta-3-carene are readily absorbed by
inhalation.
Only a minor part is exhaled unchanged and
even less is excreted unchanged in urine, showing that they are
extensively metabolised. Bioaccumulation of these terpene hydrocarbons
is not expected, since the substances are efficiently metabolised to
yield oxygenated metabolites that are subsequently conjugated with
glucuronic acid and excreted mainly in the urine.
Short description of key information on
absorption rate:
Results demonstrate rapid penetration of alpha-pinene not only to the
first stratum corneum layers but also to viable epidermis and dermis. In
an in vitro study, alpha pinene did not permeate across the skin to the
acceptor medium due to large cumulation in the skin tissue. However,
following immersion of young pigs and one human subject for 30 minutes
in baths containing 150 mL of a pine oil mixture, alpha pinene was
detected in exhaled air within 20 minutes reaching maximum levels 50-75
minutes after start of the bath and remained detectable after 1 day.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Toxicokinetic data on turpentine oil are described for delta-3-carene toxicokinetics because Turpentine oil contains the registered substance and the structurally-related substance alpha-pinene and that toxicokinetic parameters on delta-3-carene were determined after Turpentine oil exposure.
ABSORPTION AND EXCRETION:
Pulmonary uptake of delta-3-carene increased linearly with exposure, approaching 70% for 225 and 450 mg/m3 exposure levels during 2-h exposures. delta-3-Carene persists in the blood with an extended half-life, suggesting affinity for adipose tissues (Falk et al., 1991).
Eight male volunteers were exposed to 450 mg/m3 turpentine oil by inhalation (2 h, 50 W) in an exposure chamber. The mean relative uptakes of alpha pinene, beta pinene, and delta-3-carene were 62%, 66%, and 68% respectively, of the amount inhaled. Between 2% and 5% of the net uptake was excreted unchanged in the expired air after the end of exposure. The mean blood clearance 21 h after exposure (CL21h) of alpha pinene, beta pinene and delta-3-carene, were 0.8, 0.5, and 0.4 L/kg/h, respectively. The mean half lives (t1/2) of the last phase of alpha pinene, beta pinene and delta-3-carene averaged 32, 25, and 42 h, respectively. (Filipsson et al., 1996)
Elimination of turpentine oil and its metabolites is primarily through the urinary tract (Lewander and Aleguas, 1998, cited in HSDB 2003). A portion of the turpentine oil absorbed in industrial exposures is exhaled unchanged in expired air. The remainder is excreted in the urine as glucuronic acid conjugates (Bingham, 2001, cited in HSDB 2003).
The structure-related alpha pinene is readily absorbed through the pulmonary system, the skin, and the intestines (Clayton and Clayton,1981-1982; Budavari et al., 1996; cited in HSDB, 2009a and 2009b). The toxicokinetics of alpha pinene was studied in humans. Eight healthy males were exposed to 10, 225, or 450 mg/m3 (+)-alpha pinene or 450 mg/m3 (-)-alpha pinene for 2 h in an inhalation chamber while performing light work (50 watts). Average pulmonary uptake of (+)-alpha pinene and (-)-alpha pinene amounted to 59% of the exposure concentration. Absolute uptake increased linearly with concentration. Mean blood concentration at the end of exposure were linearly related to inhaled concentration. The terminal t1/2 of alpha pinene from the blood was 695 min for (+)-alpha pinene and 555 min for (-)-alpha pinene. Cumulative urinary excretion of unchanged alpha pinene amounted to less than 0.001% of each dose. Respiratory elimination of (+)-alpha pinene and (-)-alpha pinene was 7.7 and 7.5% of total uptake, respectively (Falk et al., 1990; cited in HSDB 2003 and 2009a).
Similarly, the renal elimination of verbenols after experimental exposure to (+)-alpha pinene and (-)-alpha pinene was studied in humans following exposure to 10, 225 and 450 mg/m3 terpene in an exposure chamber. The pulmonary uptake was about 60%. About 8% was eliminated unchanged in exhaled air. Depending on the exposure level, about 1%-4% of the total uptake was eliminated as cis- and trans-verbenol. Most of the verbenols were eliminated within 20 h after a 2-h exposure. The renal excretion of unchanged alpha pinene was less than 0.001%. (Levin et al., 1992, cited in HSDB 2009a)
The blood and urine monoterpene concentrations were continuously monitored from a patient attempting suicide by ingestion of 400-500 mL pine oil. The blood and urine monoterpene concentrations were continuously monitored. The data suggest that monoterpenes are poorly resorbed in the gastrointestinal tract. The resorbed portion of the hydrocarbons cumulates in the lipophilic body compartments and is slowly metabolized and then excreted by the kidneys. The main metabolic pathways are hydratation, hydroxylation, rearrangement, and acetylation (Koppel, 1981).
METABOLISM:
In a metabolism study, four healthy human volunteers were orally exposed to a single dose of 10 mg delta-3-carene (CRN) via spiked gelatin capsules. CRN-10-COOH was detected in each urine sample with maximum concentration 2-3 h after administration, whereas CRN-10-OH and CRN-3,4-OH were not detected in any of the samples. The renal excretion kinetics of CRN-10-COOH showed an elimination half-life of about 3 h. The cumulative excretion of CRN-10-COOH within 24 h after exposure correlated with about 2 % of the applied dose. The GC-PCI-MS Q1 scan analysis indicated several additional human CRN metabolites: 3% (CRN-M1), 1% (CRN-M2), 5% (CRNM3), 4% (CRN-M4), 11% (CRN-M5), and 2% (CRNM6), respectively. The results of the study indicate that CRN-10-COOH is a relevant product of the human in vivo metabolism of delta-3-carene. (Schmidt,2015)
The biotransformation of (+)-, (-)-, and (+/-)-alpha pinenes and (+)-delta-3-carene in rabbits was investigated. The major metabolites were as follows: (-)-trans-verbenol from (+)-, (-)-, and (+/-)-alpha pinenes; (-)-m-mentha-4,6-dien-8-ol, 3-caren-9-ol, (-)-delta-3-carene-9-carboxylic acid and delta-3-carene-9,10-dicarboxylic acid from (+)-delta-3-carene. (Ishida, 1981)
Similarly, the renal elimination of verbenols after experimental exposure to (+)-alpha pinene and (-)-alpha pinene was studied in humans following exposure to 10, 225 and 450 mg/m3 terpene in an exposure chamber. Depending on the exposure level, about 1%-4% of the total uptake was eliminated as cis- and trans-verbenol. Most of the verbenols were eliminated within 20 h after a 2-h exposure. The renal excretion of unchanged alpha pinene was less than 0.001%. (Levin et al., 1992, cited in HSDB 2009a)
In conclusion, bioaccumulation of these terpene hydrocarbons does not occur, since the substances are efficiently metabolised to yield oxygenated metabolites (verbenol, myrtenol and myrtenic acid) that are subsequently conjugated with glucuronic acid and excreted mainly in the urine.
HSDB (Hazardous Substances Data Bank). 2003. Turpentine. HSDB No. 204. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last updated 15 October 2003.
HSDB (Hazardous Substances Data Bank). 2009a. Alpha pinene. HSDB No. 720. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009
HSDB (Hazardous Substances Data Bank). 2009b. beta pinene. HSDB No. 5615. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009
DERMAL ABSORPTION RATE:
Skin absorption of alpha-pinene was studied using human skin mounted on flow-through diffusion cells. Similarly, the elimination kinetics in the skin were analysed during 4 h following 1-h exposure. The results demonstrate rapid penetration of alpha-pinene not only to the first stratum corneum layers but also to viable epidermis and dermis (steady-state concentrations assumed to be obtained at 1-h exposure). However, alpha-pinene did not permeate across the skin to the acceptor medium due to large cumulation in the skin tissue. Two mechanisms of elimination process of terpenes from the SC are suggested: evaporation and slightly progressive penetration from inner layer into dermis. (Cal et al., 2006)
Following immersion of young pigs and one human subject for 30 minutes in baths containing 150 mL of a pine oil mixture (Fichtennadel-Latschenkieferol Kneipp) in 450 L of water, alpha pinene, beta pinene and limonene (components of Latschenkieferol) were detected in exhaled air within 20 minutes reaching maximum levels 50-75 minutes after start of the bath and remained detectable after 1 day. (Opdyke, 1979, cited in HSDB 2009)
HSDB (Hazardous Substances Data Bank). 2009. Alpha pinene. HSDB No. 720. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
